Silencing of the long non-coding RNA GHET1 inhibits cell proliferation and migration of renal cell carcinoma through epithelial-mesenchymal transition.

In conclusion, the present study suggested that GHET1 may be considered a therapeutic target for the treatment or prevention of RCC. PMID: 30867747 [PubMed]
Source: Oncology Letters - Category: Cancer & Oncology Tags: Oncol Lett Source Type: research